143 related articles for article (PubMed ID: 33994688)
1. Immune Complex Associated Glomerulonephritis in a Patient with Prefibrotic Primary Myelofibrosis: A Case Report.
Atlani M; Sharma T; Joshi D; Kumar A
Indian J Nephrol; 2021; 31(1):50-53. PubMed ID: 33994688
[TBL] [Abstract][Full Text] [Related]
2. Focal segmental glomerulosclerosis in a patient with prefibrotic primary myelofibrosis.
Bohra GK; Meena DS; Bajpai N; Purohit A
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29728434
[TBL] [Abstract][Full Text] [Related]
3. Focal Crescentic Glomerulonephritis Superimposed on Myeloproliferative Disease-Related Glomerulopathy in a Case of Myelofibrosis.
Kunpara JA; Darji BP; Patel HA; Patwari D; Patel SS; Darji PI
Indian J Nephrol; 2024; 34(1):64-66. PubMed ID: 38645909
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated immune complex glomerulonephritis with "lupus-like" features: a clinicopathologic study of 14 cases.
Haas M; Kaul S; Eustace JA
Kidney Int; 2005 Apr; 67(4):1381-90. PubMed ID: 15780090
[TBL] [Abstract][Full Text] [Related]
5. Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.
Del Sordo R; Brugnano R; Covarelli C; Fiorucci G; Falzetti F; Barbatelli G; Nunzi E; Sidoni A
Clin Nephrol Case Stud; 2017; 5():70-77. PubMed ID: 29350220
[TBL] [Abstract][Full Text] [Related]
6. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
7. Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature.
Dias E; Liberal R; Costa-Moreira P; Príncipe F; Fonseca E; Macedo G
GE Port J Gastroenterol; 2022 Mar; 29(2):125-131. PubMed ID: 35497670
[TBL] [Abstract][Full Text] [Related]
8. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
9. Dense intramembranous deposit disease: new pathologic features.
Sibley RK; Kim Y
Kidney Int; 1984 Apr; 25(4):660-70. PubMed ID: 6482170
[TBL] [Abstract][Full Text] [Related]
10. Primary antiphospholipid antibody syndrome and mesangial IgA glomerulonephritis.
Sinniah R; Gan HC; Yoon KH
Am J Nephrol; 2001; 21(2):134-40. PubMed ID: 11359021
[TBL] [Abstract][Full Text] [Related]
11. The expanding spectrum of renal diseases associated with antiphospholipid syndrome.
Fakhouri F; Noël LH; Zuber J; Beaufils H; Martinez F; Lebon P; Papo T; Chauveau D; Bletry O; Grünfeld JP; Piette JC; Lesavre P
Am J Kidney Dis; 2003 Jun; 41(6):1205-11. PubMed ID: 12776272
[TBL] [Abstract][Full Text] [Related]
12. Focal proliferative lupus nephritis. A clinicopathologic study using the W.H.O. classification.
Magil AB; Ballon HS; Rae A
Am J Med; 1982 Apr; 72(4):620-30. PubMed ID: 7041645
[TBL] [Abstract][Full Text] [Related]
13. Atypical antiglomerular basement membranes disease with nephrotic-range proteinuria, mesangial proliferation, and membranoproliferative glomerulonephritis pattern of injury.
AlSowailmi B; AlSowailmi G; Aloudah N; Alsaad KO; Elhassan E; Al Sayyari AA
Saudi J Kidney Dis Transpl; 2017; 28(6):1397-1403. PubMed ID: 29265053
[TBL] [Abstract][Full Text] [Related]
14. Glomerular podocytopathy in patients with systemic lupus erythematosus.
Kraft SW; Schwartz MM; Korbet SM; Lewis EJ
J Am Soc Nephrol; 2005 Jan; 16(1):175-9. PubMed ID: 15548564
[TBL] [Abstract][Full Text] [Related]
15. First reported case of collagenofibrotic glomerulopathy with a full-house pattern of immune deposits.
Fukami K; Yamagishi S; Minezaki T; Nishi S; Hisano S; Okuda S
Clin Nephrol; 2014 Apr; 81(4):290-5. PubMed ID: 23036230
[TBL] [Abstract][Full Text] [Related]
16. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
Sinniah R; Feng PH
Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
[TBL] [Abstract][Full Text] [Related]
17. Glomerulopathy in Kuwait: the spectrum over the past 7 years.
El-Reshaid W; El-Reshaid K; Kapoor MM; Madda JP
Ren Fail; 2003 Jul; 25(4):619-30. PubMed ID: 12911167
[TBL] [Abstract][Full Text] [Related]
18. Non-immunoglobulin A mesangial immune complex glomerulonephritis in kidney transplants.
Giannico GA; Arnold S; Langone A; Schaefer H; Helderman JH; Shaffer D; Fogo AB
Hum Pathol; 2015 Oct; 46(10):1521-8. PubMed ID: 26245687
[TBL] [Abstract][Full Text] [Related]
19. Naproxen-induced nephropathy in systemic lupus erythematosus.
Ling BN; Bourke E; Campbell WG; Delaney VB
Nephron; 1990; 54(3):249-55. PubMed ID: 2179759
[TBL] [Abstract][Full Text] [Related]
20. IgA glomerulonephritis. Mesangial IgA deposition without systemic signs (Berger's disease).
Nagy J; Brasch H; Süle T; Hámori A; Deák G; Ambrus M
Int Urol Nephrol; 1979; 11(4):367-75. PubMed ID: 536183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
